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Abstract
Vascular endothelium actively participates in inflammatory reactions in the majority of
chronic respiratory diseases. Smoking is a major risk factor for bronchopulmonary diseases,
and it plays an important role in endothelial dysfunction development. Some experiments
prove that aggressive pollutants of tobacco smoke (benzopyrene, peroxynitrite, acrolein,
cyanides, peroxides, etc.) can cause direct damage to endothelial cells due to expression of
adhesion molecules on their surface and intensification of lipid peroxidation. In turn, oxi-
dized lipoproteins in the tunica intima of the vessel work as attractants for chemotaxis of
leukocytes and monocytes that start to produce pro-inflammatory cytokines in big amounts.
These processes trigger systemic inflammatory response that leads to irreversible thickening
of the vessel walls and deterioration of their mechanical properties. Chronic exposure to
tobacco smoke and the products of combustion of tobacco leads to chronic system inflam-
matory reaction, oxidative stress, endothelial dysfunction andmorpho-functional damage of
target organs. Nowadays, the connection between chronic obstructive pulmonary disease
(COPD) and some cardiovascular and cerebrovascular diseases has been well established.
Studying the mechanisms of endothelial dysfunction in brain blood vessels of patients with
smoking habits and COPD can be very important for preventing acute vascular events.
Keywords: endothelium, endothelial dysfunction, cardiovascular system, cerebral vessels,
smoking, respiratory diseases, COPD
1. Introduction
Vascular endothelium initiates and actively participates in inflammatory reactions in the major-
ity of chronic respiratory diseases. Endothelial dysfunction (ED) that develops as clinically
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manifested disruptions of endothelium-dependent vasomotor reactions on local and systemic
levels related with inflammation of different genesis should be regarded as a major segment of
the cardiorespiratory continuum. Endothelium can autonomously produce at least 20 biologi-
cally active substances that are synthesized and released depending on current functional
requirements. Endothelium functions create a balance of regulatory substances that determine
the whole operation of interaction and control system (Figure 1). They include factors that are
responsible for contraction and relaxation of smooth muscles in vessel walls, coagulation and
fibrinolysis, control of cell proliferation and apoptosis, regulating the reaction to foreign sub-
stances and facilitating interaction with lymph vessels and drainage.
Figure 1. Functional processes balance in normal endothelial function.
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Today there is a substantial amount of evidence proving the endothelium involvement in
development of local and systemic damage from tobacco smoke that is an indisputable cause
of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), some
phenotypes of asthma, idiopathic pulmonary fibrosis and so on [2, 7, 8, 20]. The correlation
between the intensity of tobacco smoking and rapid decline in lung function is a proven fact.
According to WHO, tobacco smokers experience sudden death five times more frequently than
non-smokers [1]. The mechanisms of damage done to the blood vessels induced by tobacco
combustion products have not been studied extensively at the moment, even though it is
accepted that tobacco does not have any exclusive ways of producing vascular damage.
Nicotine being the main component of tobacco smoke stimulates catecholamine release lead-
ing to stimulation of β1 and β2 adrenoreceptors. Nicotine induces a degradation of nitric oxide
(NO) [2]. NO induces vasodilation by stimulating soluble guanylate cyclase (GC) to produce
cyclic guanosine monophosphate (cGMP) [3]. Thus, nicotine causes change of reactions during
vasodilatation. Apart from nicotine, tobacco smoke includes 4000 chemical substances, 100 of
them having various toxic effects along with antigenic, cytotoxic, mutagenic and carcinogenic
properties [4, 5]. They are able to interfere with cellular structure and processes of intercellular
signaling by stimulating apoptosis, lipid peroxidation in cellular membrane, DNA and RNA
strings’ rupture and mitochondrial respiratory chain disruption. Tobacco smoke components
are not the only factors directly responsible for stimulating and damaging endothelium in case
of respiratory diseases; there are also endogenous factors, such as cellular and non-cellular
inflammation mediators, bacterial toxins, immune complexes, hypoxemia, free radicals and
shear stress alteration in endothelium [6–12].
In general, the sequence of events altering functional properties of endothelium can be described
as follows. Damaging factors (different in nature, intensity and length) activate and/or damage
endothelium gradually exhausting its compensation abilities and leading to abnormal (altered)
response to the same damaging factors and even to regular stimuli. It results in prolonged
vasoconstriction, higher adhesion and clotting level, weakened barrier function, intensification
of cellular proliferation and some other consequences with certain clinical symptoms: vascular
hypertension, swelling, vascular remodeling and so on. In addition, some effects, including those
related to renin-angiotensin system and endothelial involvement in inflammation process, are
both local and systemic nature.
2. Respiratory diseases and cerebral vascular endothelial dysfunction
According to modern conceptions, the central nervous system is an important participant in the
pathogenesis of a number of chronic respiratory diseases, including those having a nicotine-
associated nature. An important regulator of hemoperfusion of the brain is the vascular endothe-
lium [8]. There are specific endothelium-dependent reactions in the arteries of the brain [9, 15].
Cerebral autoregulation maintains constant blood flow (CBF) through the brain in spite of
changing mean arterial pressure. Autoregulation of cerebral blood flow consists of mechano-
and chemoregulation. Chemoregulation is in direct correlation to the serum level of carbon
dioxide and is, contrary to mechanoregulation, independent of changes in mean arterial pressure.
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Mechanoregulation depends on transmural pressure gradient and endothelial vasodilatation.
Mechanoregulation has been shown to be the main supervisory mechanism of CBF. However, it
is well established that endothelial vasodilatation of greater arteries is much more pronounced in
cerebral vasculature than elsewhere. Proper endothelial function is of crucial importance in
regulation in many vascular beds. Dysfunctional cerebral endothelium releases less endothelial
NO. As a consequence, relaxation of smooth muscle cells of small arteries is disturbed. Studies in
animals and humans have revealed that mechanoregulation is not compromised even in older
age and pathological conditions harming endothelium. On the contrary, outcomes of many
studies and clinical reports confirm the dependency of chemoregulation of CBF on vascular
endothelial integrity. Reduced chemoregulation was found in patients with dysfunctional cere-
bral endothelium [9]. The development of cognitive disorders recognized by experts as a typical
systemic manifestation of the disease remains insufficiently investigated so far in the pathogene-
sis of nicotine-associated respiratory diseases and in particular COPD [10, 11, 16, 17]. It has been
proven that one of the manifestations of vascular dysfunction can be a violation of the regional
correspondence of the blood flow, which has a significant effect on the further course of the
disease [12, 13, 18, 19]. According to research, a complex cascade of teratogenesis in respiratory
diseases initiates acute and chronic hypoxemia and, in severe cases, hypercapnia. In turn, cere-
bral dysfunction in COPD can be a factor in the violation of respiratory and vasomotor reactivity
in response to hypercapnia due to a decrease in the sensitivity of central chemoreceptors to it. It is
known that central chemoreceptors represent up to 80% of the total chemo-sensitivity of the
organism to carbon dioxide [4, 5]. The consequence of the violation of central vasomotor control
is inadequate blood supply to various areas, including the brain itself [4, 5, 15]. Not being
invalidating, violations of the central nervous system significantly affect the ability to work and
social activity of patients. The main consequence of the violation of brain perfusion in these
patients is the violation of the integral function of the central nervous system, which results in
inadequate blood supply to various areas, including the brain [5, 7, 9]. This becomes the closing
link of a peculiar “vicious circle” of regional vascular dysfunctions. Figure 2 shows the place and
role of functional imbalance of endothelium-dependent mechanisms in the pathogenesis of
respiratory diseases.
2.1. Effect of tobacco smoke components on vascular function
Consequences and mechanisms of tobacco combustion products damaging vascular bed still
require more research. Tobacco smoking is known to cause ED [19, 21] that has its peculiarities
depending on the intensity and time of exposure as well as characteristics of the arteries. For
instance, one of the crucial characteristics of cerebral blood circulation is a high level of
autonomous self-regulation providing relative independence of cerebral hemodynamics from
shifts in systemic circulation. Short-term exposure to tobacco smoke results in damage from its
toxins on vascular endothelium and activation of sympathoadrenal system. [22]. Chronic
exposure to tobacco smoke leads to a lower level of endothelial NO synthase (eNOS) activity
and NO synthesis, adhesion molecules expression on the surface of endothelial cells, protein
kinase C (PKC) activation and intensification of lipid peroxidation followed by persistent
remodeling of the vascular wall [23, 24]. Some experiments describe development of endothe-
lial dysfunction of cerebral and conductance arteries in mice exposed to tobacco smoke that
was characterized by significant intensification and predominance of constricting activity of
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arteries, as well as abnormal reduction of cerebral arterial vasodilatory reserve along with
asymmetric increase of carotid artery constriction [11, 14]. Apart from endothelial dysfunction
and alterations of vasomotor reactions in response to tobacco smoking, some experiments
revealed a connection between long-term exposure to tobacco smoke and irreversible changes
in large arteries, such as wall thickening and deterioration of their mechanical properties [24, 25].
At the same time, smoke-exposed rats showed elevated levels of elastase and progressing degen-
erative changes of thoracic and abdominal aorta accompanied by a lower quality of their elastic
and mechanical properties [26]. Some researches show that smoking increases risk of develop-
ment of abdominal aortic aneurysm (AAA). For example, AAA growth rate was lower in those
with low ankle/brachial pressure index and diabetes but higher for current smokers. No other
factor (including lipids and blood pressure) was associated with AAA growth. [27]. Current
smokers were 7.6 times more likely to have an AAA than non-smokers. Ex-smokers were 3.0
times more likely to have an AAA than non-smokers. Duration of smoking was significantly
associated with an increased risk of AAA, and there was a clear linear dose response relationship
with the duration of smoking; each year of smoking increased the relative risk of AAA by 4% [28].
Figure 2. Functional processes imbalance due to endothelial dysfunction in respiratory diseases.
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2.2. Carotid arteries condition in COPD depending on the smoking status
COPD is considered to be systemic pathology with multiple extrapulmonary effects that define
patients’ prognosis and quality of life. Smoking plays a significant part in COPD pathogenesis.
Chronic exposure to tobacco smoke works as an integral agent between topical changes of
bronchopulmonary system and systemic pro-inflammatory activation with development of
oxidative stress, endothelial dysfunction and progressing morphofunctional damage of target
organs. Today, the connection of COPD and some cardiovascular and cerebrovascular diseases
with atherosclerotic vascular damage has been proven [29, 30]. Atherosclerosis of conductance
cerebral arteries also might be both the reason for chronic brain ischemia and a sign of severe
alterations in brain blood circulation.
An important indicator of atherosclerosis is thickening of intima-media complex of carotid
arteries and development of atherosclerotic plaques that serve as markers for high risk of
developing ischemic heart disease and stroke, as shown by the data from the Cardiovascular
Health Study and Rotterdam Study [31]. Implementation of different imaging methods has
significantly broadened the horizons of atherosclerosis diagnostics. One of the methods is
ultrasound scanning of brain vessels that has some advantages, like providing extensive
information, non-invasiveness of the procedure, accessibility and relatively low cost. Also, this
method allows to get information about structural characteristics of atherosclerotic plaques,
velocity and spectral parameters of the blood flow [32]. Nowadays there is an ongoing search
for general risk factors and development mechanisms of cardiovascular and cerebrovascular
pathology in COPD.
Using transcranial Doppler ultrasound (Nicolet Companion Biomedikal, the USA), we eval-
uated some parameters of cerebral hemodynamics. The research included 75 COPD patients
(aged 54.81  8.36 years) who smoke. The control group consisted of 20 healthy volunteers
of comparable gender and age. Using carotid duplex ultrasound (MyLab 50 Esaote, Italy),
we measured intima-media thickness (IMT) of the common carotid arteries (CCA) and
middle cerebral arteries (MCA). We found thickening of the intima-media complex in the
majority of COPD patients who smoke (Figure 3). Apart from that, one-third of the exam-
ined patients had atherosclerotic plaques in the CCA bifurcation area and internal carotid
artery mouth that led to artery stenosis in up to 22.5  4.2% of cases. Parameters of velocity
are presented in Tables 1 and 2.
Some papers present convincing data on direct connection between COPD patients with
carotid atherosclerosis and air flow velocity shown by spirometry [34–36]. COPD patients are
more likely to have unstable atherosclerotic plaques with big lipid nuclei. These changes are
visible even in patients with a mild case of COPD. Lahousse et al. have discovered that
atherosclerotic plaques are very common for COPD patients in 60% of non-smoking patients
and 80% of smokers [36]. Atherosclerotic plaques in case of COPD have a high risk of rupture
even for patients with a very mild case of airway obstruction, while smoking only increases
that risk [37]. Unstable atherosclerotic plaques with big lipid nuclei appear early in COPD and
explain the doubling of mortality rates from cardiovascular diseases in this group of patients
[38]. Animal tests show that systemic inflammation in COPD releases pro-inflammatory
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mediators that facilitate inflammatory cells migration into atherosclerotic plaques, increasing
the level of lipids there and thus creating unstable plaques [39].
Exposure to smoke induces a significant thickening of intima-media complex in conductance
arteries, atherosclerotic plaques in the CCA bifurcation area and internal carotid artery mouth
Figure 3. The thickness of the intima-media complex in the common carotid arteries in COPD patients and healthy
people according to the data of ultrasound duplex scanning (mean  SD, *p < 0.05 in comparison with the control group;
t-test analysis was used to assess the differences in the values). CCA: common carotid artery. Explanations are in the text.
Parameter Control (healthy people, N = 20) COPD and smoking (patients, N = 75)
Peak systolic velocity in the right CCA, cm/s 71.5  7.3 53.1  5.5*
Mean velocity in the right CCA, cm/s 38.2  4.0 27.4  3.1*
End diastolic velocity in the right CCA, cm/s 18.4  1.6 14.9  1.5*
Peak systolic velocity in the left CCA, cm/s 72.9  8.1 53.9  5.2*
Mean velocity in the left CCA, cm/s 37.9  3.9 27.3  3.1*
End diastolic velocity in the left CCA, cm/s 18.8  1.7 15.1  1.4*
Pulsatility index in the right CCA 2.02  0.24 1.39  0.13*
Pulsatility index in the left CCA 2.04  0.25 1.50  0.16*
Resistance index in the right CCA 0.75  0.04 0.71  0.06
Resistance index in the left CCA 0.74  0.05 0.70  0.06
Data are presented as mean  SD. *p < 0.05 (t-test analysis was used to assess the differences in the values) in comparison
with the control group. COPD is chronic obstructive pulmonary disease and CCA is common carotid artery.
Table 1. Blood flow parameters from transcranial dopplerography in the common carotid artery.
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that leads to partial artery stenosis [33]. Long-term exposure to toxic products of tobacco
combustion causes hypertrophy of smooth muscle cells, disorganization of arterial myoelastic
tissue, faster lipid peroxydation leading to thickening of vessel walls, deterioration of their
mechanic properties and atherogenesis [23, 40]. It results in the lower level of arterial elasticity,
excessive rigidity of vessel walls with loss of their damping properties in response to fluctua-
tions of systemic arterial pressure and other effects of situational hemodynamic stresses, thus,
increasing the risk of arterial hypertension and worsening the prognosis for the course of the
disease [41].
Structural deterioration of conductance arteries causes alterations in blood flow velocity. At the
same time, the resistance of peripheral vessels and elastic properties of vessel wall decrease
which is indicated by lower pulsation index and, to a lesser extent, resistance index [33].
Our studies of blood flow in conductance and extracerebral arteries using transcranial
dopplerography showed reduced velocity of blood flow in common carotid arteries and
medial cerebral arteries (Tables 1 and 2). More significant changes of cerebral hemodynamics
were found in the medium velocity of blood flow. There was also a significant drop in
pulsation index and slight reduction of resistance index (Tables 1 and 2), as it has been shown
earlier [33].
Unlike CCAs, MCAs in patients with COPD demonstrate increased peripheral resistance
indexes (Table 2).
Brain arteries are frequently considered to be a system comprising interrelated but indepen-
dent segmental effectors [42, 43]. According to the conducted research, MCAs mostly have
vasospastic reactions that are reflected in the increase of both indexes characterizing peripheral
resistance level, that is, pulsatility index and resistance index. Also, MCAs in the COPD group
Parameter Control (healthy people, N = 20) COPD and smoking (patients, N = 75)
Peak systolic velocity in the right MCA, cm/s 95.8  11.1 91.2  10.6
Mean velocity in the right MCA, cm/s 56.1  4.1 48.2  3.2*
End diastolic velocity in the right MCA, cm/s 49.8  3.9 46.7  3.0
Peak systolic velocity in the left MCA, cm/s 93.8  9.8 85.2  8.8
Mean velocity in the left MCA, cm/s 56.0  4.6 44.8  3.3*
End diastolic velocity in the left MCA, cm/s 49.2  4.0 44.4  3.7
Pulsatility index in the right MCA 0.82  0.04 0.93  0.05*
Pulsatility index in the left MCA 0.81  0.04 0.93  0.04*
Resistance index in the right MCA 0.47  0.03 0.50  0.03
Resistance index in the left MCA 0.46  0.03 0.49  0.04
Data are presented as mean  SD. *p < 0.05 (t-test analysis was used to assess the differences in the values) in comparison
with the control group. COPB is chronic obstructive pulmonary disease and MCA is middle carotid artery.
Table 2. Blood flow parameters from transcranial dopplerography in the middle cerebral artery.
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show lower velocity of blood flow, but they are 2–3 times less pronounced than in CCAs and
have significant differences only in the medium velocity parameter. Since the ultimate goal of
myogenic response of conductance arteries is to maintain stable blood flow along the whole
regional vascular network [44], the discovered reduction in deviations of blood flow velocity in
MCAs from the control values is quite logical, unlike in case of the CCA results.
It is important to note that slower blood flow velocity and higher peripheral resistance indexes
in the MCAs mostly indicate not the transformation of elastic properties of the vessel but a
shift from a dilatatory function of the endothelium to a constricting one which is common for
distributional sector of blood circulation in pia matter [13, 42]. Such significant change in pial
arteries reaction can be an indicator of endothelial dysfunction resulting from a sequence of
biochemical processes triggered by toxic influence of tobacco smoke components and being a
product of systemic inflammatory response that suppresses endothelial production of vasodi-
lators, including NO [24].
An important indicator of cerebrovascular hemodynamics is the reaction of small pial and
precortical arteries that are extremely sensitive to brain blood flow alterations [42]. Breath-
holding test (hypercapnic test) and hyperventilation test (hyperoxia test) allow to calculate the
indexes of endothelium-dependent reaction of those vessels in terms of their dilatatory and
constricting functions, respectively [45, 46]. The obtained results show an existing imbalance of
endothelial vasomotor activity in small pial and cerebral vessels where vasospastic reactions
are intensified with unchanged or slightly reduced endothelial dilatation ability of these
vessels in patients with smoking-induced COPD (Figure 4) [33]. The value of vascular respon-
siveness index (VRI) was calculated as: VRI = (Vps2 Vps1)/Vps1 100%, Vps1 is peak systolic
velocity in the MCA under investigation and Vps2 is peak systolic velocity in the MCA after
Figure 4. Vascular responsiveness index (VRI) in COPD patients and healthy patients assessed by ultrasound duplex
scanning (mean  SD, *p < 0.05 in comparison with the control group; t-test analysis was used to assess the differences in
the values). VRI v/d is cerebral reactivity index to vasodilation, VRI v/c is cerebral reactivity index to vasoconstriction,
RMCA is right middle cerebral artery and LMCA is left middle cerebral artery. Explanations are in the text.
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the appropriate tests. One of the hyperoxic vasoconstriction mechanisms can be NO inactivation
by superoxide anions resulting from superoxygenation [24, 47]. As a result of those processes,
vasorelaxant effect of NO weakens; perfusion reserve and self-regulation potential of resistance
vessels are reduced while the risks of cerebrovascular pathology become higher [48].
At the same time, in the precortical arterioles, the production of vasodilator increases as an
adaptive physiological process. It leads to a vasodilatation, increase in diameter of vessels that
promotes improvement of brain perfusion as an adaptive mechanism [42]. If this does not
happen, the conditions for acute and chronic hemodynamic disorders start to develop. At the
moment, enough data have been collected to prove the close connection between one’s
smoking history and frequency of cerebrovascular events, lacunar strokes, vascular dementia
and cognitive deficiency [49–51].
2.3. Vasomotor function of cerebral vessels in tobacco smoking
An important feature of cerebral blood circulation is a high level of autonomous self-regulation
that provides relative independence and protection for cerebral hemodynamics from shifts in
systemic blood circulation. Observation has shown that smoking is an independent risk factor of
ischemic stroke for both men and women [50]. We may assume that there is an integrating
development mechanism of systemic vascular dysfunction in chronic tobacco smoking that is
also responsible for damaging brain vessels. Cerebral blood flow disruption is known to be
initiated by the failing self-regulation mechanism, and its vulnerability grows if functional and
morphological integrity of endothelium is damaged. Meta-analysis of 22 researches showed that
chronic tobacco smoking can double the relative risk of ischemic stroke [50]. Endothelial dys-
function is suggested to be a part of pathological cascade of vascular remodeling influenced by
tobacco smoking [52].
In order to study vasomotor activity of endothelium in arteries exposed to chronic tobacco
smoke in vivo, many experiments have been designed in rats [53–55]. Considering the similar-
ities between rats and humans in terms of Willis’ circle structure and its topography as well as
anatomical likeness, the use of these animals is objectively relevant for modeling different
pathologies in brain vessels with subsequent extrapolation of the result to humans. Since it is
impossible to use non-invasive dopplerography in rats, invasive method had to be used when
the rats were injected with vasodilators and vasoconstrictors. Afterwards, the diameter changes
in cerebral arteries affected by pharmacological stimuli were studied with magnetic resonance
imaging (MRI) brain scanning (Figure 5).
To assess endothelial function of cerebral arteries we used pharmacological tests that proved to
be a highly efficient and specific means for studying endothelium-dependent and endothelium-
independent mechanisms of the vasomotor activity regulation. The selected pharmacological
agents have well-known action modes and certain points of application allowing to assess the
mechanisms of vasomotor reaction development.
The study was conducted on the middle cerebral artery of mature male Wistar rats weighing
180–200 g that were divided into a control group (n = 10) and experimental group (n = 10),
respectively. The animals from the control group were breathing regular atmospheric air, while
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experimental group was exposed to inhaling tobacco smoke for 6 months to create chronic
tobacco smoke model (method by Zheng et al.) [56]. Rats of experimental group were placed in
a special chamber for inhalation, where they were exposed to tobacco smoke for 1 h in the
morning and 1 h in the daytime, 7 days in a week, for 36 weeks. Then, using MRI of the brain,
the level of change in the cerebral arteries diameter after pharmacological stimuli was assessed.
This method was used for investigating endothelium-dependent vasodilatation (EDVD) after the
acetylcholine (ACh) injection, endothelium-independent vasodilatation (EIVD) after the nitro-
glycerin injection, endothelium-dependent vasoconstriction (EDVC) after the N-monomethyl-L-
arginine (L-NMLA) injection and endothelium-independent vasoconstriction (EIVC) after the
norepinephrine injection. Cerebral vascular reactivity index (CVRI) was used to describe vaso-
motor function of the endothelium. CVRI was calculated using the formula: CVRI = (d2-d1):
(d3-d1), where d1 is the the initial diameter of the artery, d2 is diameter of the artery EDVD and
d3 is the diameter of the artery EDVC. BrainMRI was performed on the scanner for experimental
studies “PharmaScan US 70/16” (Bruker, Germany).
The study showed vascular dysfunction in cerebral blood circulation of animals chronically
exposed to tobacco smoke [57]. Data indicating vasomotor function of brain arteries in rat
smokers are presented in Table 3.
Figure 5. The chart (A) and a MRI tomographic image (B) of the cerebral arteries in the sagittal plane in rats (chronic
tobacco smoke model, experimental group). Chart A shows a contour of the tomographic scan area. Arrows in tomo-
graphic image point to approximate locations of the measurements of the arteries indicated by numbers: 1: Middle
cerebral arteries, 2: Facial arteries, 3: Internal carotid arteries, 4: External carotid arteries. Explanations are in the text.
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Pharmacological tests caused expected endothelium-dependent and endothelium-independent
vasodilation in healthy rats proving that NO synthase and GC mechanisms of vascular endothe-
lium dilation remained intact [57].
At the same time, our results showed significant differences in vasomotor reactions of rats
exposed to tobacco smoking. ACh stimulates eNOS causing NO secretion that results in pro-
nounced EDVD [58]. Our results showed that the control group of rats exhibited an expected,
sufficient level of EDVD in their brain vessels. Furthermore, arterial diameter increased by more
than 10% of the original level in healthy rats indicating that the Enos-mediated mechanism of
vasodilation remained intact (Table 3).
Alternatively, the group of smokers had pathological vasospastic reactions after ACh adminis-
tration (Table 3). The reason might be related to functional damage of vascular endothelium.
Some experiments showed that chronic exposure to tobacco smoke causes NO deficiency and
weaker activity of eNOS [59, 60]. Based on previous mechanistic reports [53–55], we can
assume that there is an NO deficiency and lower level of endothelial eNOS activity in our
model of tobacco smoking that indicates substantial damage of eNOS mechanism and thus
impaired vasodilation.
Apart from the eNOS mechanism of vasodilation, there is also another one involving GC. NO
molecule is a highly active radical due to its unpaired electron. Its chemical properties allow it
to access vascular myocytes and activate intracellular GC without any receptors. As a result,
the cell concentration of cGMP becomes higher, and smooth muscle cells relax [61, 62]. GC
mechanism of vasodilation was studied by injecting rats with nitroglycerin as the NO donor.
The control group of rats had an expected level of EIDVD induced by nitroglycerin. In
addition, arterial diameter increases by more than 15% of the original level indicates that GC
endothelium-independent mechanism of vasodilation in healthy rats remained intact [63].
Chronic smokers’ group had insufficient vasodilation after the same stimulation that indicates
damages in both eNOS and GC mechanisms of vasodilation in animal smokers. Some authors
believe that weaker response of vascular smooth muscle cells to nitrovasodilators might be
initiated by hypoxia that exists in long-term smoking [52, 64–66].
Analysis of the constricting section in the smokers’ group shows pathological vasodilation in
response to L-NMMA constrictor administration and pronounced constriction after norepinephrine
Descriptor Control (rats, N = 10) Tobacco smoking (rats, N = 12)
EDVD, % +11.89  0.98 0.64  0.02*
EIDVD, % +17.84  1.25 + 8.64  0.76*
EDVC, % 6.31  0.14 +5.95  0.34*
EIDVC, % 4.83  0.12 11.2  1.01*
Data are presented as mean  SD. *p < 0.05 (t-test analysis was used to assess the differences in the values) in comparison
with the control group. EDVD, endothelium-dependent vasodilation; EIDVD, endothelium-independent vasodilation;
EDVC, endothelium-dependent vasoconstriction; EIDVC, endothelium endothelium-independent vasoconstriction; %,
percent change after the appropriate tests.
Table 3. Vasomotor function of cerebral arteries in smoking.
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injection [57]. L-NMMA test allows us to evaluate consistency of adrenergic mechanisms
of vascular tone regulation and endothelium-dependent vasoconstriction [57]. L-NMMA
directly inhibits eNOS and indirectly inhibits inducible NOS (iNOS). Its injection helps to
reduce NO production in endothelial cells and abolishes the NO-dependent dilation of vessels
[67, 68].
At any specific time, vascular tone is defined by the balance of constricting and dilating
influence on vascular smooth muscle cells. VRI of vasodilation in the smokers’ group was
15 times lower than required (VRI for the control group is 1.88  0.11; VRI for the smokers’
group is 0.12  0.08; p < 0.001) that indicates a significant damage of endothelial vasomotor
function due to predominant pathological constricting reactions (Figure 6).
3. Conclusion
Endothelium initiates and modulates the main pathomorphological processes of chronic respira-
tory diseases. In particular, endothelium activation is an important factor of initiation, develop-
ment and persistence of inflammation and vessels and tissue remodeling; it contributes to lymph
circulation dysfunction and development of systemic effects. Endothelial cells of different vessels
are morphologically and functionally oriented toward optimal regulation of organs’ blood supply
by synthesizing and releasing locally acting mediators. Pathology of endothelial cells can develop
selectively: the cells are sensitive to hypoxia, tobacco smoke influence, products of inflammatory
response, peroxidation, ischemic disorders, swelling and so on. Vessel remodeling usually starts
as adaptation to hemodynamic changes or activity of tissue and circulating humoral factors.
Long-term adaptation is replaced by vessel structure deterioration as a response to damaging
factors, including toxic components of tobacco smoke and metabolites and atherogenic factors
or changes of hemodynamic load. Cognitive dysfunction in cases of chronic nicotine-associated
Figure 6. Vascular responsiveness index (VRI) of cerebral arteries in rats obtained by MRI scanning (chronic tobacco
smoke model, experimental group, results are presented as mean  SD, *p < 0.05 in comparison with the control group;
t-test analysis was used to assess the differences in the values).
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diseases is recognized by the majority of medical experts as one of the systemic symptoms of such
diseases and a big medical and socioeconomic challenge. Studying the peculiarities of endothe-
lium dysfunction caused by chronic exposure to tobacco smoke is relevant for finding a way of
treating progressing cognitive deficiency and developing personalized methods of preventing
acute vascular events.
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